| abstract |
Provided herein and methods and systems for diagnosis of chronic prostatitis (CP) and/or chronic pelvic pain syndrome (CPPS). In particular, methods and systems are provided for monitoring levels of biomarkers of mast cell activity (e.g., mast cell tryptase, carboxypeptidase A3 (CPA3), etc.) in a sample from a subject (e.g., urine, expressed prostatic secretions (EPS), etc.), diagnosing the subject as suffering from CP/CPPS based thereon, and/or treating a subject for CP/CPPS based thereon. |